Inventor
DING CHARLES Z
CN80 patents
⚠️ This page may combine multiple inventors who share the name “DING CHARLES Z”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS5547966AAug 20, 1996
Aryl urea and related compounds
BRISTOL MYERS SQUIBB CO125 citations97
US6916813B2Jul 12, 2005
(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
BRISTOL MYERS SQUIBB CO80 citations96
US6011029AJan 4, 2000
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO107 citations96
US5869478AFeb 9, 1999
Sulfonamido substituted benzopyran derivatives
BRISTOL MYERS SQUIBB CO45 citations93
US6875782B2Apr 5, 2005
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO46 citations92
US6602883B1Aug 5, 2003
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO23 citations92
US6458783B1Oct 1, 2002
Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO29 citations92
US6387926B1May 14, 2002
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO38 citations92
US6156746ADec 5, 2000
1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
BRISTOL MYERS SQUIBB CO36 citations92
US5837702ANov 17, 1998
4-arylamino-benzopyran and related compounds
BRISTOL MYERS SQUIBB CO25 citations92
US6455523B1Sep 24, 2002
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO17 citations91
US7279485B2Oct 9, 2007
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO11 citations83
US6624157B2Sep 23, 2003
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO4 citations63
US7951793B2May 31, 2011
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO2 citations62
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
6 patentsUS9969719B2May 15, 2018
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD9 citations82
US11358950B2Jun 14, 2022
SMAC mimetics used as IAP inhibitors and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations70
US10626107B2Apr 21, 2020
Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations70
US12516057B2Jan 6, 2026
Crystalline form of TLR8 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations62
US12054482B2Aug 6, 2024
TLR8 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations62
US12221432B2Feb 11, 2025
Estrogen receptor antagonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations61
MEDSHINE DISCOVERY INC
6 patentsUS11623923B2Apr 11, 2023
Uracil compound as c-MET/AXL inhibitor
MEDSHINE DISCOVERY INC2 citations71
US11459323B2Oct 4, 2022
Monocyclic β-lactam compound for treating bacterial infection
MEDSHINE DISCOVERY INC3 citations70
US11453667B2Sep 27, 2022
Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor
MEDSHINE DISCOVERY INC2 citations70
US10227362B2Mar 12, 2019
Anti-pulmonary tuberculosis nitroimidazole derivative
MEDSHINE DISCOVERY INC1 citations62
US11691974B2Jul 4, 2023
3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors
MEDSHINE DISCOVERY INC1 citations61
US11655248B2May 23, 2023
Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor
MEDSHINE DISCOVERY INC0 citations59
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD
3 patentsUS10519143B2Dec 31, 2019
Substituted-indole-compounds as estrogen receptor down-regulators
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD3 citations70
US11034653B2Jun 15, 2021
Crystal form of estrogen receptor inhibitor and preparation method therefor
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD2 citations67
US12098127B2Sep 24, 2024
Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD0 citations58
FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD
3 patentsUS11465986B2Oct 11, 2022
Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor
FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD0 citations61
US11807647B2Nov 7, 2023
Crystal form of hepatitis B surface antigen inhibitor and application thereof
FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD0 citations60
US12103936B2Oct 1, 2024
Crystal form of hepatitis B surface antigen inhibitor
FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD0 citations55
CUMBRE IP VENTURES L P
2 patentsGENFLEET THERAPEUTICS SHANGHAI INC
2 patentsUS10548883B2Feb 4, 2020
Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor
GENFLEET THERAPEUTICS SHANGHAI INC1 citations60
US11236112B2Feb 1, 2022
Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor
GENFLEET THERAPEUTICS SHANGHAI INC0 citations59
CUMBRE PHARMACEUTICALS INC
2 patentsHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC
2 patentsUS10941150B2Mar 9, 2021
Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC0 citations59
US10428073B2Oct 1, 2019
Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC1 citations59
SHENZHEN OPTIMUM BIOLOGICAL TECH CO LTD
2 patentsHARBIN ZHENBAO PHARMACEUTICAL CO LTD
2 patentsANACOR PHARMACEUTICALS INC
1 patentAKAMA TSUTOMU
1 patentNANJING SANHOME PHARMACEUTICAL CO LTD
1 patentQILU PHARMACEUTICAL CO LTD
1 patentZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD
1 patentCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD
1 patentShowing the top 50 of 80 patents by PatentIndex Score.